A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Apr 22, 2024
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers ...
Gender
ALL
Eligibility criteria
- Patient Inclusion Criteria:
- • Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- • Must have a current diagnosis of new or recurrent stage II-IV lung cancer
- • Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
- • Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
- • Must s elf-report receiving unpaid care from a caregiver who meets the study caregiver criteria and who is willing to participate
- Caregiver Inclusion Criteria:
- • Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
- • Must self-report providing the majority of the unpaid care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
- • Must have access to the internet at home or be willing to use CONNECT in the clinic
- • Must have access to telephone to complete sessions with the central caregiver navigator
- Patient Exclusion Criteria:
- • Post-treatment survivors at the time of study enrollment
- • Enrolled in hospice care
- • Unable to read and English and not willing to have someone read surveys for them
- Caregiver Exclusion Criteria:
- • Self-report currently receiving cancer treatment
- • Unable to read and communicate in English, as the CONNECT intervention is currently only available in English
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Memphis, Tennessee, United States
Milwaukee, Wisconsin, United States
Augusta, Georgia, United States
Wilkes Barre, Pennsylvania, United States
Spartanburg, South Carolina, United States
Scranton, Pennsylvania, United States
Honolulu, Hawaii, United States
Springfield, Missouri, United States
Appleton, Wisconsin, United States
Greenville, South Carolina, United States
Greenville, South Carolina, United States
Green Bay, Wisconsin, United States
Kenosha, Wisconsin, United States
Denver, Colorado, United States
Rehoboth Beach, Delaware, United States
Columbus, Mississippi, United States
Grenada, Mississippi, United States
New Albany, Mississippi, United States
Oxford, Mississippi, United States
Southhaven, Mississippi, United States
Gaffney, South Carolina, United States
Greer, South Carolina, United States
Union, South Carolina, United States
Collierville, Tennessee, United States
Neenah, Wisconsin, United States
'Aiea, Hawaii, United States
Osage Beach, Missouri, United States
Winston Salem, North Carolina, United States
Millville, Delaware, United States
Lafayette, Colorado, United States
Lone Tree, Colorado, United States
Patients applied
Trial Officials
Kathryn Weaver, PhD
Study Chair
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported